SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?


To: StockDoc who wrote (874)12/1/1998 7:46:00 AM
From: Dr. John M. de Castro  Read Replies (1) | Respond to of 887
 
DepoCyt approval may occur very soon. Ligand announced yesterday that they received an approvable letter from the FDA. They were reviewed by ODAC on the same day that DEPO's DepoCyt was reviewed. The FDA is already very familiar with DepoCyt and has reviewed all of the safety and manufacturing data previously. So, it would seem reasonable to expect an approvable letter for DepoCyt to be issued very soon.

biz.yahoo.com